Effettuare il login Iscriviti gratis

Hancock Jaffe Laboratories Inc Avanti P/E

Cos'è Avanti P/E di Hancock Jaffe Laboratories Inc?

Avanti P/E di Hancock Jaffe Laboratories Inc è -6.70

Qual è la definizione di Avanti P/E?



Il rapporto prezzo / utili a termine è il rapporto tra il prezzo delle azioni di una società e l'utile stimato per azione della società per i prossimi dodici mesi.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Avanti P/E di aziende nel Health Care settore su NASDAQ rispetto a Hancock Jaffe Laboratories Inc

Cosa fa Hancock Jaffe Laboratories Inc?

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

Aziende con avanti p/e simili a Hancock Jaffe Laboratories Inc